Progressive multifocal leukoencephalopathy during treatment with lenalidomide and elotuzumab for multiple myeloma
- 18 May 2020
- journal article
- letter
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 61 (9), 2234-2237
- https://doi.org/10.1080/10428194.2020.1765237
Abstract
(2020). Progressive multifocal leukoencephalopathy during treatment with lenalidomide and elotuzumab for multiple myeloma. Leukemia & Lymphoma. Ahead of Print.This publication has 15 references indexed in Scilit:
- Lenalidomide-associated progressive multifocal leukoencephalopathyLeukemia & Lymphoma, 2017
- Progressive multifocal leukoencephalopathy after autologous peripheral blood stem cell transplantation in a patient with multiple myeloma treated with combination therapyJournal of the Neurological Sciences, 2016
- Clinical Pharmacokinetics and Pharmacodynamics of LenalidomideClinical Pharmacokinetics, 2016
- Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myelomaJournal of Pharmacokinetics and Pharmacodynamics, 2016
- Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rashTherapeutics and Clinical Risk Management, 2015
- Elotuzumab Therapy for Relapsed or Refractory Multiple MyelomaThe New England Journal of Medicine, 2015
- Longitudinal Monitoring with Multiple MR Techniques in a Case of Progressive Multifocal Leukoencephalopathy Associated with Multiple MyelomaMagnetic Resonance in Medical Sciences, 2014
- Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment optionBMJ Case Reports, 2011
- Progressive multifocal leukoencephalopathy in a patient with multiple myelomaInternational Journal of Hematology, 2010
- Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapyBone Marrow Transplantation, 2010